Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc

<< Previous

Bullboard Posts

Next >>

Post by Trogarzonon Dec 14, 2022 9:46am

152 Views

Post# 35170592

Christmas magic maybe

Sometimes everything looks so gloomy that something good happens or something is triggered like a takout. Either Nash deal saves Crhristmas or Pfizer puts 4$ on the table and taps Paul on the shoulder for bringing down the price tab for Th assets that turn out to be ok in afew months.. by magic. I'm speculating of course.

<< Previous

Bullboard Posts

Next >>

3 Mid-Sized Stocks to Consider This Season